2024 was a tough year for the biopharma industry, with several companies cutting hundreds or even thousands of employees. Follow along as BioSpace tracks job cuts and restructuring initiatives throughout 2025.
Vaxart Cuts 10% of Staff After US Government Orders Vaccine Trial Halt